Test Price
2,800 AED✅ Home Collection Available
HSPB1 Gene CMT2F Genetic Test – NGS Sequencing & Neuropathy Diagnosis in Dubai
Executive Summary & Core Metrics
Executive Summary: The HSPB1 gene test employs Next‑Generation Sequencing (NGS) to detect pathogenic variants associated with Charcot‑Marie‑Tooth disease type 2F (CMT2F). Our ISO 9001:2015 accredited laboratory (certificate: INT/EGQ/2509DA/3139) delivers 99.9% diagnostic sensitivity across the full coding region. The service includes VIP mobile phlebotomy with temperature‑controlled cold‑chain home collection (daily 8 AM–11 PM), secure courier specimen transport, and a telephonic genetic counseling session for result interpretation. Insurance coverage verification is available via WhatsApp at +971 54 548 8731. All processes comply with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Test Overview & Methodology
The HSPB1 NGS test provides comprehensive coverage of the HSPB1 gene, identifying missense, nonsense, splice‑site, and small indel variants. It is indicated for individuals with clinical suspicion of axonal CMT2F, progressive distal weakness, or family history of hereditary neuropathy. The methodology includes library preparation, paired‑end sequencing on Illumina platforms, and variant interpretation according to ACMG/AMP guidelines.
| Feature | Our NGS Test | Standard Sanger Sequencing |
|---|---|---|
| Diagnostic Precision | 99.9% sensitivity (full gene coverage) | ~95% (targeted exons only) |
| Methodology | NGS – Next Generation Sequencing | Sanger capillary electrophoresis |
| Turnaround Time | 3 – 4 weeks | 6 – 10 weeks |
| Clinical Interpretation | Comprehensive report with variant classification (ACMG) | Basic mutation detection, limited insight |
Physician Insight & Safety Protocols
“A genetic result must be interpreted in the context of a complete neurological examination. While this test can confirm a suspected CMT2F diagnosis, it does not replace specialist clinical evaluation. I strongly advise patients not to alter any prescribed medication without direct consultation with their treating physician.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Safety Advisory
- This test is not intended for emergency diagnosis. Do not delay urgent medical care while awaiting results.
- All sample collection adheres to ISO 9001:2015 cold‑chain and infection‑control standards.
- Patients with known bleeding disorders or on anticoagulant therapy should consult their physician before blood draw.
Exclusion Criteria & Red Flags
- Excluded populations: Individuals who are hemodynamically unstable, or those unable to provide informed consent without a legal guardian (in accordance with Federal Decree‑Law No. 4 of 2016 on Medical Liability).
- Red Flags – Seek immediate medical attention if you experience sudden limb weakness, difficulty breathing, or severe neuropathic pain.
Patient FAQ & Clinical Guidance
1. What sample is required for the HSPB1 gene test?
We accept whole blood, a dried blood spot on an FTA card, or extracted DNA. Our VIP mobile phlebotomy service can collect the sample at your home, workplace, or hotel in Dubai, ensuring a convenient and painless experience.
2. How long do results take?
Results are delivered within 3 to 4 weeks via our secure online portal, accompanied by a detailed clinical interpretation report and telephonic counseling from our genetics team.
3. Is the test covered by insurance in the UAE?
Many UAE health insurance plans cover genetic testing for hereditary neuropathies when medically indicated. We verify your coverage instantly via WhatsApp at +971 54 548 8731.
4. Can the test be performed on children?
Yes, with informed consent from a parent or legal guardian. The sample collection process is minimally invasive and safe for pediatric patients.
UAE Regulatory & Data Privacy Adherence
All genetic data is processed and stored in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Your health information is encrypted, access‑controlled, and never shared without explicit consent as per the UAE’s stringent data privacy framework. We adhere to the ISO 27001 information security standard across all laboratory and digital platforms.
Clinical & Logistical Metadata
| Test Name | HSPB1 Gene CMT2F Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks (14–21 Business Days) |
| Sample Type / Matrix | Whole Blood, FTA Card (Dried Blood Spot), or Extracted DNA – VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (Available daily from 8 AM to 11 PM) |
| Methodology Used | Next‑Generation Sequencing (NGS) on Illumina Platform |
| ICD-10-CM Code | G60.0 |
| LOINC Code | 55233-1 |
| DHA Facility License & Laboratory Address | DNA Labs UAE – DHA License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians